Tennis Icon’s Deadly Health Battle Returns

Chris Evert’s latest cancer announcement is painful news, but the bigger story is how openly she is facing a disease that has already come back before.

Story Snapshot

Evert said her ovarian cancer returned after CT and PET scans raised concern.^[1]^[3]
She said she already had surgery and will start chemotherapy soon.^[1]^[3]
She plans to miss Wimbledon and step back from work while she focuses on treatment.^[1]^[3]
Her history includes a BRCA1 gene mutation and prior ovarian cancer diagnoses in 2021 and 2023.^[2]^[3]^[6]

What Evert Said and What News Outlets Reported

Chris Evert personally announced that her ovarian cancer had returned, and she linked the news to recent CT and PET scans. NBC News reported that she said she had already undergone surgery and would begin chemotherapy in the coming weeks.

People and Today reported the same core facts, including her plan to step away from Wimbledon and other work commitments while she recovers.^[1]^[2]^[3]

That matters because this was not a vague health update. It was a direct statement from one of tennis’s most recognizable figures, and it gave fans a clear picture of what comes next: surgery behind her, chemotherapy ahead, and a lighter public schedule for now. For a sports world that likes neat headlines, her message was far more human than tidy.^[1]^[3]

A Long Battle With Cancer, Not a One-Time Scare

Evert’s diagnosis carries weight because this is not her first fight. Reported accounts say she was first diagnosed with ovarian cancer in 2021, later described herself as cancer-free, and then faced another recurrence in late 2023.

Yahoo Health also reported that she has a BRCA1 gene mutation, which is tied to a higher risk of certain cancers. That history helps explain why she has been monitored so closely.^[2]^[3]^[4]^[6]

People reported that Evert gets CT and PET scans every three months to watch for another return of the disease. That kind of close follow-up is not unusual for someone with her medical background, but it does show how fragile remission can be.

A scan can look clean one season and raise alarms the next. That is the part many readers miss when they hear the word “remission.”^[8]

Why Her Story Lands So Hard

Evert is more than a former champion. She is a public face people trust, and that gives her health news extra force. NBC News noted that she also said she would miss Wimbledon, which makes the announcement feel immediate and real rather than abstract.

For fans, the loss is not only personal. It is also symbolic. One of tennis’s steadiest voices is once again forced to put health first.^[1]

Her family history adds another layer. NBC News reported that her sister Jeanne Evert Dubin died of ovarian cancer in 2020, and that loss led Evert to genetic testing and the BRCA1 discovery.

That detail matters because it shows how often cancer stories are built from grief, warning signs, and hard lessons learned too late. Evert’s openness turns a private fear into a public warning.^[2]

What Is Still Unknown

The public record still relies mainly on Evert’s own announcement and the news coverage that repeated it. No pathology report or formal hospital statement has been made public, and the exact scan findings have not been shared in detail.

That does not make the report doubtful. It simply means the public is hearing the story through Evert, not through a full medical file.^[1]^[2]^[3]

That gap is common in celebrity cancer stories. Research on public health coverage shows that these reports often leave out key clinical details, even when the headline is accurate.

Social media can spread a cancer update fast, but it can also strip away the medical context readers need. Evert’s case shows both sides of that tradeoff at once.^[13]

Tennis Hall of Famer Chris Evert says she will miss Wimbledon after recurrence of ovarian cancer https://t.co/MMbPMuHATU

— Channel 3 News (@wcax) June 28, 2026

For now, the central fact is simple: Chris Evert says her ovarian cancer has returned, and she is moving into treatment again. The rest is the harder part, the part that unfolds in private, one scan and one treatment at a time.^[1]^[3]